Clinical Trial

ADAPT - A Patient Registry of the Real-world Use of Orenitram®

Study acronym: ADAPT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, observational, multicenter, patient registry will follow patients who are receiving treatment with Orenitram for the treatment of PAH for up to 78 weeks from Orenitram initiation
Protocol Amendment History 18 amendments
This ClinicalTrials.gov record has been amended 18 times since 2017-02-06; most recent amendment 2026-03-27.
Status change: Recruiting → Active, Not Recruiting 2022-09-19
Status change: Not Yet Recruiting → Recruiting 2017-07-18
Trial Details
NCT Number NCT03045029
Lead Sponsor United Therapeutics
Conditions Pulmonary Arterial Hypertension
Enrollment 300 participants
Start Date 2017-07-18
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-02